Drug Shortage Report for EPIPEN JR
Report ID | 37657 |
Drug Identification Number | 00578657 |
Brand name | EPIPEN JR |
Common or Proper name | EPIPEN JR |
Company Name | MYLAN SPECIALTY LP |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE |
Strength(s) | 0.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | Each (0.15MG/0.3ML AUTO-INJECTOR) |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-04-16 |
Actual start date | 2018-04-16 |
Estimated end date | |
Actual end date | 2019-02-19 |
Shortage status | Resolved |
Updated date | 2019-02-20 |
Company comments | |
Health Canada comments | http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67330a-eng.php |
Tier 3 Status | No |
Contact Address | 3711 COLLINS FERRY ROAD MORGANTOWN, WEST VIRGINIA UNITED STATES 26505 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.